First Horizon (FHN) Rule 144 Notice: 100K Shares Proposed Sale
Rhea-AI Filing Summary
Form 144 notice for First Horizon Corporation (FHN) shows a proposed sale of 100,000 common shares through Raymond James & Associates on 08/22/2025, with an aggregate market value of $2,244,514.05 and 507,747,624 shares outstanding. The filing lists the securities as previously acquired as restricted stock across multiple grant dates from 02/14/2015 to 05/12/2021, totaling recorded lots (e.g., 3,447; 15,316; 9,989; 6,242; 15,520; 18,267; 12,764; 11,979). It also discloses recent sales by David T. Popwell on 07/22/2025 totaling 38,010 shares for gross proceeds of $843,834.52. The filer certifies no undisclosed material adverse information.
Positive
- Full disclosure of proposed sale including broker, date, share count, and market value
- Origin of shares documented (restricted stock grant dates from 2015–2021), supporting transparency
Negative
- Insider selling activity (100,000 proposed shares and 38,010 recently sold) which may be perceived negatively by some investors
- No trading plan date disclosed in the remarks that would indicate scheduled liquidity rather than opportunistic selling
Insights
TL;DR: Insider plans to sell 100,000 shares (~$2.24M) after prior disposals, likely routine Rule 144 liquidity management.
The filing documents a proposed Rule 144 sale of 100,000 common shares with an aggregate value of $2.24M via Raymond James on 08/22/2025. The shares originated from multiple restricted stock grants between 2015 and 2021, indicating long-held compensation rather than recent acquisitions. Recent open-market sales by David T. Popwell on 07/22/2025 totaled 38,010 shares for $843,834.52, showing active disposition activity ahead of the proposed block. For investors, this is a disclosure of executive/insider selling under Rule 144 rather than a corporate operational update; absent other company disclosures, the information is procedural and liquidity-related.
TL;DR: Multiple past restricted grants being monetized; filing contains standard attestations and no unusual restrictions disclosed.
The schedule of acquisitions shows restricted stock grants from 2015 through 2021 in modest lot sizes, consistent with compensation vesting. The notice includes the statutory representation that the seller is unaware of undisclosed material adverse information. No trading plan date or additional restrictions are provided in the remarks. This looks like routine compliance with Rule 144 for an insider sale and does not by itself indicate governance concerns, though continued or large-scale selling could be monitored.